Concepedia

Yu Shen

YS

Statistics

Publications

206

Citations

16.3K

H-Index

65

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AbbVie (United States)

Abbott (United States)

Yu Shen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1996–2025

206

Publications

206

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

Gideon Steinbach, Patrick M. Lynch, Robin Phillips et al. · New England Journal of Medicine · 2000 · 2.5K citations · Full text

, , +13

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text

, , +17

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Padmanee Sharma, Yu Shen, Sijin Wen et al. · Proceedings of the National Academy of Sciences · 2007 · 517 citations

, , +17

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Emily J. Faivre, Keith F. McDaniel, Daniel H. Albert et al. · Nature · 2020 · 404 citations

, , +10

Acquired Resistance to BET-PROTACs (Proteolysis-Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 Ligase Complexes

Lu Zhang, Bridget Riley‐Gillis, Priyanka Vijay et al. · Molecular Cancer Therapeutics · 2019 · 342 citations

, , +13

1–5 of 206